Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
Wuhan Easy Diagnosis Biomedicine Co Ltd
Cash from Operating Activities
Wuhan Easy Diagnosis Biomedicine Co Ltd
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Wuhan Easy Diagnosis Biomedicine Co Ltd
SZSE:002932
|
Cash from Operating Activities
¥4B
|
CAGR 3-Years
463%
|
CAGR 5-Years
144%
|
CAGR 10-Years
N/A
|
|
A
|
APT Medical Inc
SSE:688617
|
Cash from Operating Activities
¥689.1m
|
CAGR 3-Years
67%
|
CAGR 5-Years
106%
|
CAGR 10-Years
N/A
|
J
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SZSE:002223
|
Cash from Operating Activities
¥2.9B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
41%
|
CAGR 10-Years
38%
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
Cash from Operating Activities
¥12.1B
|
CAGR 3-Years
37%
|
CAGR 5-Years
30%
|
CAGR 10-Years
N/A
|
|
L
|
Lepu Medical Technology Beijing Co Ltd
SZSE:300003
|
Cash from Operating Activities
¥1.6B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
5%
|
CAGR 10-Years
18%
|
Shanghai United Imaging Healthcare Co Ltd
SSE:688271
|
Cash from Operating Activities
¥682.8m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
4B
CNY
Based on the financial report for Dec 31, 2022, Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Operating Activities amounts to 4B CNY.
What is Wuhan Easy Diagnosis Biomedicine Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
144%
Over the last year, the Cash from Operating Activities growth was 256%. The average annual Cash from Operating Activities growth rates for Wuhan Easy Diagnosis Biomedicine Co Ltd have been 463% over the past three years , 144% over the past five years .